FDA Recall of Medline ARTHROSCOPY PACK Due to Regulatory Clearance Issues
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP is recalling 27 units of ARTHROSCOPY PACK because the regulatory clearances for certain components have been rescinded.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action, a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, Devices) map to related alerts in the same area of risk - browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
FDA Recall of Medline ARTHROSCOPY PACK
What Happened
The recall was initiated due to the rescinding of 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing in the affected kits.
Which Products Are Affected
The affected product is Medline Kits: ARTHROSCOPY PACK, Model Number: DYNJ82440. This involves 27 units with UDI-DI: 10195327196240 (each), 40195327196241 (case), and Lot Number: 24BMD005. The products were distributed nationwide in the United States.
What You Should Do
Consumers should contact the recalling firm, Medline Industries, LP, at their address: 3 Lakes Dr, Northfield, IL 60093-2753, as per the initial firm notification letter for further instructions on the recall.
Why This Matters
This recall affects medical devices distributed across the United States, potentially impacting the safety and regulatory compliance of healthcare products.
Source
FDA Recall Notice: Attribution to FDA event ID 98599, recall number Z-1850-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.